Beauty brands can command eye-popping prices, whether they’re celebrity-founded and internet-famous or built around a doctor’s name. E.l.f. Beauty agreed to pay up to $1 billion for Hailey Bieber’s Rhode, Coty paid $600 million for 51% of Kylie Cosmetics, and Shiseido spent $450 million on Dr. Dennis Gross Skincare.
Now Blackstone is testing whether a far less famous skincare name can command an even higher valuation. The investment firm is exploring a sale of ZO Skin Health that could value the company at around $2 billion, Reuters reported this week, citing people familiar with the matter. Unlike celebrity-driven brands such as Rhode or Kylie Cosmetics, ZO built much of its business not through influencers or department stores but through dermatologists and medical-aesthetics practices.
